Literature DB >> 1713122

Secretion of gamma-glutamyl hydrolase in vitro.

B M O'Connor1, R F Rotundo, Z Nimec, J J McGuire, J Galivan.   

Abstract

gamma-Glutamyl hydrolase (also known as conjugase) is a ubiquitous enzyme that has the capacity to cleave folyl- and antifolylpolyglutamates. This study has revealed that the enzyme is secreted by primary cultures of rat hepatocytes and by H35 hepatoma cells. H35 cells have lower cellular levels of gamma-glutamyl hydrolase than do hepatocytes but secrete a greater proportion of gamma-glutamyl hydrolase. More than 99% of the total enzyme from H35 cells accumulated in the medium after 48 h. The cells were shown to remain intact during the secretion period since lactate dehydrogenase, dihydrofolate reductase, and lysosomal hydrolases other than gamma-glutamyl hydrolase were retained within the cell. Using the substrate 4-amino-10-methyl-pteroyldiglutamate (4-NH2-10-CH3-Pte-Glu2), the intracellular and secreted enzyme form(s) from H35 cells were found to have the following properties (a) Km values of 24.3 +/- 3.7 microM and 34.8 +/- 8.6 microM, respectively, and (b) maximal activity at pH 5 to 7 and apparent molecular weights of 120,000 by gel filtration. Both the cellular and secreted enzymes convert 4-NH2-10-CH3-PteGlu4 and pteroylpentaglutamate acid, to the corresponding monoglutamates with little or no appearance of intermediate chain length polyglutamates. This suggests that both act primarily as endopeptidases. Thus far, the cellular and secreted enzymes cannot be differentiated although the current studies do not establish this point unequivocally. Alterations in the cellular and secreted H35 cell gamma-glutamyl hydrolase levels in response to changes in culture conditions revealed that glutamine enhances activity while insulin diminishes it. Other transformed cells found to secrete this protein are Hep-G2 human hepatoma, JAR human choriocarcinoma, HeLa, and rat glioma. gamma-Glutamyl hydrolase could not be detected in medium conditioned by human MCF-7 breast cancer cells, and relatively low activities were found in the medium from CCRF-CEM or K562 leukemia cells. These studies directly establish for the first time the secretion of gamma-glutamyl hydrolase in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713122

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Prodrug forms of N-[(4-deoxy-4-amino-10-methyl)pteroyl]glutamate-gamma-[psiP(O)(OH)]-glutarate, a potent inhibitor of folylpoly-gamma-glutamate synthetase: synthesis and hydrolytic stability.

Authors:  Yan Feng; James K Coward
Journal:  J Med Chem       Date:  2006-01-26       Impact factor: 7.446

2.  Site-directed mutagenesis establishes cysteine-110 as essential for enzyme activity in human gamma-glutamyl hydrolase.

Authors:  K J Chave; J Galivan; T J Ryan
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

3.  Human gamma-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro.

Authors:  R Yao; E Schneider; T J Ryan; J Galivan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

4.  The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis.

Authors:  Ilan Ifergan; Gerrit Jansen; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

5.  Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy.

Authors:  Courtney Pollard; Matt Nitz; Alex Baras; Paul Williams; Christopher Moskaluk; Dan Theodorescu
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

6.  Humanizing mouse folate metabolism: conversion of the dual-promoter mouse folylpolyglutamate synthetase gene to the human single-promoter structure.

Authors:  Chen Yang; Lin-Ying Xie; Jolene J Windle; Shirley M Taylor; Richard G Moran
Journal:  FASEB J       Date:  2014-02-14       Impact factor: 5.191

7.  High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.

Authors:  Nathaniel Melling; Masoud Rashed; Cornelia Schroeder; Claudia Hube-Magg; Martina Kluth; Dagmar Lang; Ronald Simon; Christina Möller-Koop; Stefan Steurer; Guido Sauter; Frank Jacobsen; Franziska Büscheck; Corinna Wittmer; Till Clauditz; Till Krech; Maria Christina Tsourlakis; Sarah Minner; Hartwig Huland; Markus Graefen; Lars Budäus; Imke Thederan; Georg Salomon; Thorsten Schlomm; Waldemar Wilczak
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

8.  High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Authors:  Emman Shubbar; Khalil Helou; Anikó Kovács; Szilárd Nemes; Shahin Hajizadeh; Charlotta Enerbäck; Zakaria Einbeigi
Journal:  BMC Cancer       Date:  2013-02-01       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.